Hoth Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview

Rocket One

24/03/2025 20:02

Hoth Therapeutics Inc HOTH.OQ HOTH.O is expected to show no change in quarterly revenue when it reports  results on March 26 (estimated) for the period ending December 31 2024

​LSEG's mean analyst estimate for Hoth Therapeutics Inc is for a loss of 37 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Hoth Therapeutics Inc is $4.50​, above​ its last closing price of $1.08. ​​​

This summary was machine generated March 24 at 20:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)